| Resource | PE 009-9 PIC/S Guide to Good Manufacturing Practices for Medicinal Products (Part II) | dbartel |
| Resource | PE 009-9 PIC/S Guide to Good Manufacturing Practices for Medicinal Products (Part I) | dbartel |
| Resource | PE 009-9 PIC/S Guide to Good Manufacturing Practices for Medicinal Products (Introduction) | dbartel |
| Resource | FDA Inspector's Technical Guide: The Computer in FDA Regulated Industry Part II | dbartel |
| Resource | FDA Inspector's Technical Guide: The Computer in FDA Regulated Industry | dbartel |
| Resource | Hoffman DDS, 3/08 | dbartel |
| Resource | Behavioral Therapeutics, 4/08 | dbartel |
| Resource | Polymer Technologies Systems, 4/08 | dbartel |
| Resource | Philips Medical Systems, 4/08 | dbartel |
| Resource | Stratec Medizintechnik, 9/08 | dbartel |
| Resource | Whitney Labs, 9/08 | dbartel |
| Resource | IBA Molecular, 10/08 | dbartel |
| Resource | BioMedix Vascular Solutions, 10/08 | dbartel |
| Resource | FDA Docket 2007-N-0379: Changes to 21 CFR 211 cGMP for Finished Pharmaceuticals | dbartel |
| Resource | Steris, 9/08 | dbartel |
| Resource | FDA 21 CFR 56: Institutional Review Boards | dbartel |
| Resource | FDA 21 CFR 50: Protection of Human Subjects | dbartel |
| Resource | FDA 21 CFR 210: cGMP in Manufacturing, Processing, Packing, or Holding of Drugs | dbartel |
| Resource | FDA 21 CFR 606: cGMP for Blood and Blood Components | dbartel |
| Resource | FDA 21 CFR 58: Good Laboratory Practice for Nonclinical Laboratory Studies | dbartel |
| Resource | FDA 21 CFR 211: cGMP for Finished Pharmaceuticals | dbartel |
| Webinar Video | System Audit Readiness Presentation | praxismi |
| Resource | PE 010-3 PIC/S Guide to Good Practices for the Preparation of Medicinal Products in Healthcare Establishments | dbartel |
| Resource | FDA Guidance: Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers | dbartel |
| Resource | Fall Prevention Technologies, 8/08 | dbartel |
